Cargando…
Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
Tumour antigen-induced inhibition of leucocyte adherence was modified for use in glass test tubes (Tube LAI assay) for the study of cell-mediated anti-tumour immunity to human malignant melanoma. Peripheral blood leucocytes (PBL) of 20 out of 25 patients (80%) with active malignant melanoma responde...
Autores principales: | Marti, J. H., Thomson, D. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1976
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025156/ https://www.ncbi.nlm.nih.gov/pubmed/962991 |
Ejemplares similares
-
The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
por: Lopez, M., et al.
Publicado: (1978) -
A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
por: O'Connor, R., et al.
Publicado: (1978) -
Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.
por: Vose, B. M., et al.
Publicado: (1979) -
Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition Test
por: Halliday, W. J., et al.
Publicado: (1974) -
Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
por: Dusheiko, G. M., et al.
Publicado: (1979)